JPH07223939A - ミオイノシトールを含有する糖尿病治療剤および栄養組成物 - Google Patents

ミオイノシトールを含有する糖尿病治療剤および栄養組成物

Info

Publication number
JPH07223939A
JPH07223939A JP6340632A JP34063294A JPH07223939A JP H07223939 A JPH07223939 A JP H07223939A JP 6340632 A JP6340632 A JP 6340632A JP 34063294 A JP34063294 A JP 34063294A JP H07223939 A JPH07223939 A JP H07223939A
Authority
JP
Japan
Prior art keywords
composition
inositol
myo
therapeutic agent
total
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6340632A
Other languages
English (en)
Japanese (ja)
Inventor
Harry L Green
エル グリーン ハリー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of JPH07223939A publication Critical patent/JPH07223939A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/37—Sugar alcohols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/801—Peptide sweetners

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pediatric Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP6340632A 1993-12-22 1994-12-20 ミオイノシトールを含有する糖尿病治療剤および栄養組成物 Pending JPH07223939A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17381493A 1993-12-22 1993-12-22
US173,814 1993-12-22

Publications (1)

Publication Number Publication Date
JPH07223939A true JPH07223939A (ja) 1995-08-22

Family

ID=22633617

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6340632A Pending JPH07223939A (ja) 1993-12-22 1994-12-20 ミオイノシトールを含有する糖尿病治療剤および栄養組成物

Country Status (6)

Country Link
US (1) US5763392A (enExample)
EP (1) EP0659349A1 (enExample)
JP (1) JPH07223939A (enExample)
AU (1) AU8163394A (enExample)
CA (1) CA2137431A1 (enExample)
TW (1) TW282398B (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004203863A (ja) * 2002-12-09 2004-07-22 Taisho Pharmaceut Co Ltd 抗糖尿病用組成物
JP2006213684A (ja) * 2005-02-07 2006-08-17 Hokko Chem Ind Co Ltd インスリン抵抗性改善に用いられる組成物及び健康用食品
JP2007051132A (ja) * 2005-07-19 2007-03-01 Hokkaido Sugar Co Ltd イノシトールを成分とする食用組成物または医薬組成物
JP2012065675A (ja) * 1998-06-05 2012-04-05 Nutrinia Ltd インスリンを補った乳児用調製乳
JP2020532985A (ja) * 2017-09-07 2020-11-19 スイート センス インコーポレーテッド 低血糖性糖組成物

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9601395D0 (sv) * 1996-04-12 1996-04-12 Dieter Haeussinger New therapeutic treatment 1
NO301574B1 (no) * 1996-06-27 1997-11-17 Jan Oxholm Gordeladze Energidrikk
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
ES2201467T3 (es) * 1997-03-27 2004-03-16 Michael J. Sole Composicion nutritiva para la mejora energetica de la celula.
BR0010014A (pt) * 1999-04-27 2002-01-15 Insmed Pharm Inc Composição farmacêutica compreendendo um inositol e um ìon de metal para melhorar sensibilidade à insulina e metabolismo de glucose
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
CA2439793A1 (en) * 2001-03-02 2002-09-12 Lichtwer Pharma Ag Composition for the treatment of diabetes mellitus
AU2003262804A1 (en) 2002-08-22 2004-03-11 Nutrition 21, Inc. Arginine silicate inositol complex and use thereof
DE10260263A1 (de) * 2002-12-20 2004-07-15 Biocrates Life Sciences Gmbh Verwendung von Tetrahydrobiopterinderivaten zur Behandlung und Ernährung von Patienten mit Aminosäurestoffwechselstörungen
HUE029533T2 (en) * 2003-11-17 2017-03-28 Biomarin Pharm Inc Treatment of phenylketonuria with BH4
EP2436379A1 (en) * 2004-11-17 2012-04-04 BioMarin Pharmaceutical Inc. Stable tablet formulation
US7763650B2 (en) * 2006-03-15 2010-07-27 Medipharma S.A. Pharmaceutical compound and method
MX2010000660A (es) * 2009-12-11 2011-06-14 Abbott Lab Soluciones de rehidratacion oral que comprenden dextrosa.
ITMI20110445A1 (it) * 2011-03-22 2012-09-23 Lo Li Pharma Srl Formulazione farmaceutica comprendente inositolo.
KR101867620B1 (ko) 2011-07-01 2018-06-18 가부시키가이샤 시세이도 혈소판 유래 성장 인자-ｂｂ 생성 항진제, 및 그것을 포함하는 간엽계 줄기세포 생성 촉진제, 줄기세포 안정화제, 및 진피 재생화제
TWI582110B (zh) * 2011-07-01 2017-05-11 Shiseido Co Ltd Platelet-derived growth factor-BB produces hyperactivity agents, and is associated with leaf-derived stem cell-producing accelerators, stem cell stabilizers, and dermal regenerators
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
US20140328970A1 (en) * 2013-05-03 2014-11-06 Mead Johnson Nutrition Company Nutritional Composition Comprising Whey and Hydrolyzed Casein and Uses Thereof
WO2016020488A1 (en) * 2014-08-08 2016-02-11 Nestec S.A. Myo-inositol and probiotics and uses
CN106659222A (zh) * 2014-08-08 2017-05-10 雀巢产品技术援助有限公司 肌醇和益生菌及其用途
MX2017001737A (es) 2014-08-08 2017-04-27 Nestec Sa Vitamina b2 y sus usos.
MX385029B (es) 2014-08-08 2025-03-14 Soc Des Produits Nestle S A Star Una combinacion de vitamina d y zinc y su uso.
WO2016020495A1 (en) * 2014-08-08 2016-02-11 Nestec S.A. Myo-inositol and one or more probiotic and use thereof
US11191735B2 (en) 2015-03-13 2021-12-07 Nutrition 21, Llc Arginine silicate for periodontal disease
US10525016B2 (en) 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
US20170135969A1 (en) 2015-11-12 2017-05-18 Jds Therapeutics, Llc Topical arginine-silicate-inositol for wound healing
CN109890384A (zh) 2016-09-01 2019-06-14 Jds治疗有限公司 生物素镁组合物和使用方法
MX2021005213A (es) 2018-11-02 2021-09-08 Nutrition 21 Llc Composiciones que contienen complejos de silicato de arginina estabilizado con inositol y inositol para mejorar funciones cognitivas en jugadores de videojuegos.
IL294021A (en) 2019-12-16 2022-08-01 Nutrition 21 Llc Methods of production of arginine-silicate complexes
CN111772022A (zh) * 2020-05-25 2020-10-16 唐传生物科技（厦门）有限公司 一种低gi健康糖及其制备方法和用途
AU2021295104A1 (en) * 2020-06-22 2022-12-08 Société des Produits Nestlé S.A. Compositions comprising myo-inositol and their use in the prevention of post partum haemorrhage (pph)
CA3188423A1 (en) 2020-09-04 2022-03-10 Francois-Pierre Martin Compositions and methods for providing health benefits in an animal
WO2023183767A1 (en) * 2022-03-21 2023-09-28 Abbott Laboratories Methods and compositions for increasing insulin sensitivity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4497800A (en) * 1982-07-06 1985-02-05 Mead Johnson & Company Stable liquid diet composition
US4921877A (en) * 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance
DE69033560T2 (de) * 1989-03-08 2001-03-01 The University Of Virginia Patent Foundation, Charlottesville Arzneimittel für insulinresistente diabetiker
AU7584891A (en) * 1990-03-19 1991-10-21 Brigham And Women's Hospital Treatment of osmotic disturbance with organic osmolytes

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012065675A (ja) * 1998-06-05 2012-04-05 Nutrinia Ltd インスリンを補った乳児用調製乳
JP2004203863A (ja) * 2002-12-09 2004-07-22 Taisho Pharmaceut Co Ltd 抗糖尿病用組成物
JP2006213684A (ja) * 2005-02-07 2006-08-17 Hokko Chem Ind Co Ltd インスリン抵抗性改善に用いられる組成物及び健康用食品
JP2007051132A (ja) * 2005-07-19 2007-03-01 Hokkaido Sugar Co Ltd イノシトールを成分とする食用組成物または医薬組成物
JP2020532985A (ja) * 2017-09-07 2020-11-19 スイート センス インコーポレーテッド 低血糖性糖組成物

Also Published As

Publication number Publication date
EP0659349A1 (en) 1995-06-28
CA2137431A1 (en) 1995-06-23
AU8163394A (en) 1995-06-29
TW282398B (enExample) 1996-08-01
US5763392A (en) 1998-06-09

Similar Documents

Publication Publication Date Title
JPH07223939A (ja) ミオイノシトールを含有する糖尿病治療剤および栄養組成物
Dry et al. Effect of a fish oil diet on asthma: results of a 1-year double-blind study
US8017651B2 (en) Compositions and methods for the treatment of HIV-associated fat maldistribution and hyperlipidemia
Dangin et al. Influence of the protein digestion rate on protein turnover in young and elderly subjects
TWI452969B (zh) 含有長鏈多不飽和脂肪酸之營養補充品
AU2003266400B2 (en) Leucine-enriched nutritional compositions
JP5574561B2 (ja) 総合経腸栄養組成物
CN103096735B (zh) 用于营养缺乏的营养补充组合物及其使用方法
US20010022980A1 (en) Dietary supplement for individuals under stress
BRPI0620244A2 (pt) uso de uma fração de lipìdeos, composição, formulação em pó antialérgica para bebe, e, uso de uma composição
JPWO2003022288A1 (ja) 血糖値コントロール用栄養組成物
JPH08500332A (ja) 炎症性疾患の治療のための非経口的に投与される医薬を調製するためのエマルジョンの使用
JPH0716076A (ja) 喫煙者のための調製物
US20120045426A1 (en) Compositions for reducing the deleterious effects of stress and aging
JP2022524491A (ja) 中鎖トリグリセリド（ｍｃｔ）からのケトン産生を増加させるために食前にｍｃｔの投与を用いる方法
Martinez Polyunsaturated Fatty Acids in the Developing Human Brain, Red Cells and
Ayling Clinical biochemistry of nutrition
TW201507627A (zh) 包含乳清和經水解之酪蛋白之營養組成物及彼之用途
JP2016102064A (ja) 脂質代謝促進剤
French et al. Polyunsaturated fat in the diet may improve intestinal function in patients with Crohn's disease
Yeh et al. Impairment of lipid emulsion metabolism associated with carnitine insufficiency in premature infants
Winters et al. Linolenic acid provides a source of docosahexaenoic acid for artificially reared rat pups
Koletzko et al. Effects of a formula supplement rich in linoleic acid on the essential fatty acid status of cystic fibrosis patients
JP2000119180A (ja) 経腸栄養剤
WO2024237195A1 (ja) 子どもの発達促進のための組成物